Logo image of FIVE

FIVE BELOW (FIVE) Stock Fundamental Analysis

USA - NASDAQ:FIVE - US33829M1018 - Common Stock

146.96 USD
+7.06 (+5.05%)
Last: 9/15/2025, 6:26:27 PM
146 USD
-0.96 (-0.65%)
After Hours: 9/15/2025, 6:26:27 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to FIVE. FIVE was compared to 121 industry peers in the Specialty Retail industry. While FIVE has a great health rating, its profitability is only average at the moment. FIVE is valued quite expensively, but it does show have an excellent growth rating. These ratings could make FIVE a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

FIVE had positive earnings in the past year.
In the past year FIVE had a positive cash flow from operations.
In the past 5 years FIVE has always been profitable.
In the past 5 years FIVE always reported a positive cash flow from operatings.
FIVE Yearly Net Income VS EBIT VS OCF VS FCFFIVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

1.2 Ratios

With a decent Return On Assets value of 5.93%, FIVE is doing good in the industry, outperforming 75.21% of the companies in the same industry.
FIVE has a better Return On Equity (14.32%) than 71.90% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.11%, FIVE is in the better half of the industry, outperforming 66.12% of the companies in the same industry.
FIVE had an Average Return On Invested Capital over the past 3 years of 8.48%. This is below the industry average of 12.11%.
Industry RankSector Rank
ROA 5.93%
ROE 14.32%
ROIC 7.11%
ROA(3y)7.16%
ROA(5y)7.3%
ROE(3y)17.41%
ROE(5y)18.22%
ROIC(3y)8.48%
ROIC(5y)9.59%
FIVE Yearly ROA, ROE, ROICFIVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

With an excellent Profit Margin value of 6.45%, FIVE belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
In the last couple of years the Profit Margin of FIVE has declined.
The Operating Margin of FIVE (8.26%) is better than 80.17% of its industry peers.
In the last couple of years the Operating Margin of FIVE has declined.
Looking at the Gross Margin, with a value of 35.06%, FIVE is in line with its industry, outperforming 47.11% of the companies in the same industry.
In the last couple of years the Gross Margin of FIVE has remained more or less at the same level.
Industry RankSector Rank
OM 8.26%
PM (TTM) 6.45%
GM 35.06%
OM growth 3Y-21.23%
OM growth 5Y-6.62%
PM growth 3Y-12.57%
PM growth 5Y-7.15%
GM growth 3Y-1.19%
GM growth 5Y-0.89%
FIVE Yearly Profit, Operating, Gross MarginsFIVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

7

2. Health

2.1 Basic Checks

FIVE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for FIVE has been reduced compared to 1 year ago.
FIVE has less shares outstanding than it did 5 years ago.
FIVE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FIVE Yearly Shares OutstandingFIVE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
FIVE Yearly Total Debt VS Total AssetsFIVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

FIVE has an Altman-Z score of 3.58. This indicates that FIVE is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.58, FIVE is doing good in the industry, outperforming 78.51% of the companies in the same industry.
There is no outstanding debt for FIVE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.58
ROIC/WACC0.74
WACC9.62%
FIVE Yearly LT Debt VS Equity VS FCFFIVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

FIVE has a Current Ratio of 1.71. This is a normal value and indicates that FIVE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.71, FIVE is in the better half of the industry, outperforming 75.21% of the companies in the same industry.
FIVE has a Quick Ratio of 1.71. This is a bad value and indicates that FIVE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of FIVE (0.85) is better than 74.38% of its industry peers.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 0.85
FIVE Yearly Current Assets VS Current LiabilitesFIVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

7

3. Growth

3.1 Past

FIVE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.30%, which is quite good.
FIVE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.07% yearly.
The Revenue has grown by 13.88% in the past year. This is quite good.
Measured over the past years, FIVE shows a quite strong growth in Revenue. The Revenue has been growing by 15.99% on average per year.
EPS 1Y (TTM)10.3%
EPS 3Y0.6%
EPS 5Y10.07%
EPS Q2Q%50%
Revenue 1Y (TTM)13.88%
Revenue growth 3Y10.82%
Revenue growth 5Y15.99%
Sales Q2Q%23.71%

3.2 Future

Based on estimates for the next years, FIVE will show a very strong growth in Earnings Per Share. The EPS will grow by 30.76% on average per year.
Based on estimates for the next years, FIVE will show a quite strong growth in Revenue. The Revenue will grow by 16.48% on average per year.
EPS Next Y-3.9%
EPS Next 2Y3.17%
EPS Next 3Y8.53%
EPS Next 5Y30.76%
Revenue Next Year17.07%
Revenue Next 2Y13.6%
Revenue Next 3Y11.94%
Revenue Next 5Y16.48%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
FIVE Yearly Revenue VS EstimatesFIVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
FIVE Yearly EPS VS EstimatesFIVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5 10 15 20

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 26.38, the valuation of FIVE can be described as expensive.
66.94% of the companies in the same industry are more expensive than FIVE, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.27. FIVE is around the same levels.
Based on the Price/Forward Earnings ratio of 27.39, the valuation of FIVE can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of FIVE is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of FIVE to the average of the S&P500 Index (22.77), we can say FIVE is valued slightly more expensively.
Industry RankSector Rank
PE 26.38
Fwd PE 27.39
FIVE Price Earnings VS Forward Price EarningsFIVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as FIVE.
72.73% of the companies in the same industry are more expensive than FIVE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 23.48
EV/EBITDA 13.03
FIVE Per share dataFIVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

FIVE has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.62
EPS Next 2Y3.17%
EPS Next 3Y8.53%

0

5. Dividend

5.1 Amount

No dividends for FIVE!.
Industry RankSector Rank
Dividend Yield N/A

FIVE BELOW

NASDAQ:FIVE (9/15/2025, 6:26:27 PM)

After market: 146 -0.96 (-0.65%)

146.96

+7.06 (+5.05%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-27 2025-08-27/amc
Earnings (Next)12-02 2025-12-02
Inst Owners108.39%
Inst Owner Change4.78%
Ins Owners0.95%
Ins Owner Change3.95%
Market Cap8.10B
Analysts73.1
Price Target162.77 (10.76%)
Short Float %5.99%
Short Ratio2.57
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.15%
Min EPS beat(2)3.28%
Max EPS beat(2)29.03%
EPS beat(4)4
Avg EPS beat(4)44.81%
Min EPS beat(4)1.27%
Max EPS beat(4)145.65%
EPS beat(8)5
Avg EPS beat(8)21.71%
EPS beat(12)7
Avg EPS beat(12)22.92%
EPS beat(16)8
Avg EPS beat(16)19.36%
Revenue beat(2)1
Avg Revenue beat(2)-0.09%
Min Revenue beat(2)-1.55%
Max Revenue beat(2)1.37%
Revenue beat(4)2
Avg Revenue beat(4)0.56%
Min Revenue beat(4)-1.55%
Max Revenue beat(4)3.58%
Revenue beat(8)2
Avg Revenue beat(8)-0.86%
Revenue beat(12)3
Avg Revenue beat(12)-0.68%
Revenue beat(16)4
Avg Revenue beat(16)-0.82%
PT rev (1m)17.32%
PT rev (3m)47.3%
EPS NQ rev (1m)1706.5%
EPS NQ rev (3m)3322.24%
EPS NY rev (1m)1.18%
EPS NY rev (3m)2.38%
Revenue NQ rev (1m)4.26%
Revenue NQ rev (3m)4.54%
Revenue NY rev (1m)2.49%
Revenue NY rev (3m)4.06%
Valuation
Industry RankSector Rank
PE 26.38
Fwd PE 27.39
P/S 1.92
P/FCF 23.48
P/OCF 14.51
P/B 4.25
P/tB 4.25
EV/EBITDA 13.03
EPS(TTM)5.57
EY3.79%
EPS(NY)5.36
Fwd EY3.65%
FCF(TTM)6.26
FCFY4.26%
OCF(TTM)10.13
OCFY6.89%
SpS76.74
BVpS34.58
TBVpS34.58
PEG (NY)N/A
PEG (5Y)2.62
Profitability
Industry RankSector Rank
ROA 5.93%
ROE 14.32%
ROCE 9.49%
ROIC 7.11%
ROICexc 8.7%
ROICexgc 8.7%
OM 8.26%
PM (TTM) 6.45%
GM 35.06%
FCFM 8.16%
ROA(3y)7.16%
ROA(5y)7.3%
ROE(3y)17.41%
ROE(5y)18.22%
ROIC(3y)8.48%
ROIC(5y)9.59%
ROICexc(3y)9.94%
ROICexc(5y)11.39%
ROICexgc(3y)9.94%
ROICexgc(5y)11.39%
ROCE(3y)11.31%
ROCE(5y)12.79%
ROICexcg growth 3Y-24.82%
ROICexcg growth 5Y-8.07%
ROICexc growth 3Y-24.82%
ROICexc growth 5Y-8.07%
OM growth 3Y-21.23%
OM growth 5Y-6.62%
PM growth 3Y-12.57%
PM growth 5Y-7.15%
GM growth 3Y-1.19%
GM growth 5Y-0.89%
F-Score6
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 116.61%
Cap/Sales 5.04%
Interest Coverage 250
Cash Conversion 104.92%
Profit Quality 126.41%
Current Ratio 1.71
Quick Ratio 0.85
Altman-Z 3.58
F-Score6
WACC9.62%
ROIC/WACC0.74
Cap/Depr(3y)229.46%
Cap/Depr(5y)263.43%
Cap/Sales(3y)8.65%
Cap/Sales(5y)9.26%
Profit Quality(3y)40.25%
Profit Quality(5y)53.87%
High Growth Momentum
Growth
EPS 1Y (TTM)10.3%
EPS 3Y0.6%
EPS 5Y10.07%
EPS Q2Q%50%
EPS Next Y-3.9%
EPS Next 2Y3.17%
EPS Next 3Y8.53%
EPS Next 5Y30.76%
Revenue 1Y (TTM)13.88%
Revenue growth 3Y10.82%
Revenue growth 5Y15.99%
Sales Q2Q%23.71%
Revenue Next Year17.07%
Revenue Next 2Y13.6%
Revenue Next 3Y11.94%
Revenue Next 5Y16.48%
EBIT growth 1Y-3.55%
EBIT growth 3Y-12.71%
EBIT growth 5Y8.3%
EBIT Next Year50.8%
EBIT Next 3Y25.67%
EBIT Next 5Y30.4%
FCF growth 1Y92.51%
FCF growth 3Y39.02%
FCF growth 5YN/A
OCF growth 1Y27.54%
OCF growth 3Y9.51%
OCF growth 5Y18.16%